title: Drug candidates derailed in case of mistaken identity.
authors.forename: Heidi
authors.initials: H
authors.lastname: Ledford
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides / Q000494:pharmacology* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data*; D055808:Drug Discovery / Q000592:standards / Q000706:statistics & numerical data*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D061325:Hereditary Breast and Ovarian Cancer Syndrome / Q000188:drug therapy / Q000235:genetics; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy; D010793:Phthalazines / Q000494:pharmacology / Q000627:therapeutic use; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D015203:Reproducibility of Results; D012107:Research Design / Q000706:statistics & numerical data*; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010793:Phthalazines; D010879:Piperazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; C090712:iniparib; C531550:olaparib